Welcome to Davipharm
the one you trust
Domestic manufacturer with European standards
Emblematic of the foreign investment
HP Zone and EU-GMP
On 16 April 2021, Davipharm announced the certification of Vietnam’s first High Potency (HP) Drugs Zone for production of cytotoxic/cytostatic oral solids. These are oncological drugs in hard shell capsules, tablets, and coated tablets. Davipharm’s portfolio includes 28 high potency (HP) drugs, among them oncology drugs for treatment of breast cancer, leukemia, pancreas, colorectal, stomach, cervix, prostate and lung cancer and glioblastoma. We have the capacity to produce batches from 15kg to 100kg with an annual output of 500 million units of HP drugs. While the total capacity of the factory is 1,8 billion units a year. In August 2021, despite pandemic challenges, Davipharm managed to organize and pass the virtual EU-GMP audit, becoming one of a few EU-GMP certified local drug manufacturers in Vietnam.